The past 20 years have seen important advances in understanding rare demyelinating central nervous system disorders including neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD).
This microlearning, which should take around 30 minutes to complete, summarises the current understanding of NMOSD and MOGAD, including characteristic features, the most recent diagnostic criteria and the growing availability of effective treatment options.
Following completion of the activity, you should be better able to:
Stay tuned—your next step in advancing care for NMOSD and MOGAD begins here!
All Blogposts, e-learning Courses, e-Newsletters, e-Newsflashes and the website content of MS Nurse PRO is originally created in English (UK).
Our Educational Read Blogposts and our e-learning courses are reviewed by our scientific committee on accuracy and objectiveness.
Next, the content is auto-translated by Microsoft Translator and made available on our platform.
The translated content is not language reviewed with the exception of our e-learning Course content.
MS Nurse PRO has put a process in place to have our e-learning Courses language reviewed by native speaking experts (nurses or neurologists).
We make all translated e-learning Courses available immediately and next, the language review process is started. This review process can take several months.
